A26T (p.Ala26Thr) variant of CD7 (T-cell antigen CD7)
A26T (p.Ala26Thr) in CD7 (T-cell antigen CD7) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.05 / 1. The record also includes population frequency data.
A26T (p.Ala26Thr) variant details
- p.Ala26Thr
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.0502
- REVEL 0.03
- CADD 0.00
- PolyPhen-2 0.05
- SIFT 0.96
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available